Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome

Annals of Surgery

Volumn 228, Issue 4, 1998, Pages 479-490

  Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SIZE; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; TREATMENT CONTRAINDICATION;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032471223     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199810000-00005     Document Type: Conference Paper

References (33)

1. Starzl TE, Putnam CW, eds. Experience in Hepatic Transplantation. Philadelphia, PA: WB Saunders Co. 1969;3-8.
2. MacDougal BRD, Williams R. Indications and assessment for orthotopic liver transplantation. In: Calne RY, ed. Liver Transplantation. London, England: Grune & Stratton 1983; 59-66.
3. Olthoff KM, Millis JM, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990; 125:1261-1268.
4. Pichlmayr R. Is there a place for liver grafting in malignancy? Transplant Proc 1988; 20(suppl):478-482.
5. Hart J, Busuttil RW, Lewin KJ. Disease recurrence following liver transplantation. Am J Surg 1990; 14(suppl):79-91.
6. Iwatsuki S, Gordon RD, Shaw BW, et al. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202:401-407.
7. O'Grady JG, Poison RJ, Rolles K, et al. Liver transplantation for malignant disease: results in 93 consecutive patients. Ann Surg 1988; 207:373-379.
8. Ringe B, Wittekind C, Bechstein WO, et al. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989; 209:88-98.
9. Jenkins RL, Pinson CW, Stone MD. Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 1989; 23(suppl):S104-S109.
10. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110:726-735.
11. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994; 219:236-247.
12. Ojogho ON, Esquivel CO, Imperial J, et al. Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Arch Surg 1996; 131(9):935-939.
13. Marsh JW, Iwatsuki S, Fung JJ, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997; 26(2):444-450.
14. Michel J, Escat J, Fourtanier G, et al. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 1997; 26(6):1274-1280.
15. Colella G, Forti D, Ideo G, et al. Liver transplantation for hepatocellular carcinoma: prognostic factors associated with long-term survival. Transpl Int 1996; 9 (Suppl) 1:S109-S111.
16. Crafa F, Mouiel J, Pepe S, et al. DNA flow cytometry in patients undergoing liver transplantation for hepatocellular carcinoma. Transpl Int 1996; 9 (Suppl) 1:S112-S114.
17. Ko S, Nakano H, Shimomura H, et al. Liver transplantation for hepatocellular carcinoma: consideration from the findings on autopsy. Transpl Proc 1996; 28(3):1691-1692.
18. Wong PY, Williams R, Naoumov NV, et al. Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma. Am J Gastroenterol 1995; 90(1):29-34.
19. Olthoff KM, Rosove NH, Shackleton CR, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 1995; 221:734-743.
20. Stone MJ, Klintmalm BG, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 1993; 104:196-202.
21. Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163:387-394.
22. Majno PE, Azoulay D, Perrin H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226(6):688-701.
23. Venook AP, Lake JR, Ascher NL, et al. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg 1995; 1(4):242-248.
24. Schwartz ME, Miller CM, Guy S, et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 1995; 180(5):596-603.
25. Figueras J, Casais L, Moreno P, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997; 25(6):1485-1489.
26. Spreafico C, Marchiano A, Regalia E, et al. Chememoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994; 192:687-690.
27. Ravikumar TS, Steele GD. Hepatic cryosurgery. Surg Clin North Am 1989; 69:433-440.
28. UNOS 1996 Annual Report. United Network for Organ Sharing, Richmond, VA.
29. UNOS 1997 Annual Report. United Network for Organ Sharing, Richmond, VA.
30. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997; 26(4):877-883.
31. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 1995; 21(2):403-407.
32. Lemoine A, Debuire B, Bismuth H, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg 1997; 226(1):43-50.
33. Yamanaka N, Okamoto E, Fujihara S, et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer 1992; 70:2263-2267.